NPI: 1083984082 · TEXARKANA, AR 71854 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 01/06/2012
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 01/06/2012 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 11,298 | $96K |
| 2019 | 12,295 | $100K |
| 2020 | 13,434 | $124K |
| 2021 | 14,831 | $154K |
| 2022 | 11,988 | $127K |
| 2023 | 5,524 | $60K |
| 2024 | 2,448 | $50K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 27,328 | 1,459 | $218K |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 20,993 | 1,636 | $163K |
| 83970 | 716 | 524 | $95K | |
| 82728 | 397 | 358 | $65K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 14,887 | 1,135 | $65K |
| 83550 | 368 | 332 | $34K | |
| 83540 | 383 | 344 | $29K | |
| 85041 | 1,121 | 970 | $11K | |
| A4657 | Syringe, with or without needle, each | 1,209 | 1,115 | $8K |
| J1756 | Injection, iron sucrose, 1 mg | 2,970 | 749 | $8K |
| 85048 | 1,069 | 930 | $8K | |
| 82947 | 68 | 59 | $3K | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 75 | 50 | $1K |
| G0008 | Administration of influenza virus vaccine | 48 | 29 | $997.35 |
| 90674 | 38 | 37 | $354.30 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 129 | 80 | $173.18 |
| 0124A | 19 | 12 | $50.55 |